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To determine if fatal infections caused by different high-
ly virulent inﬂ  uenza A viruses share the same pathogenesis, 
we compared 2 different inﬂ  uenza A virus subtypes, H1N1 
and H5N1. The subtypes, which had shown no pathoge-
nicity in laboratory mice, were forced to evolve by serial 
passaging. Although both adapted viruses evoked diffuse 
alveolar damage and showed a similar 50% mouse lethal 
dose and the same peak lung concentration, each had a 
distinct pathologic signature and caused a different course 
of acute respiratory distress syndrome. In the absence of 
any virus labeling, a histologist could readily distinguish in-
fections caused by these 2 viruses. The different histologic 
features described in this study here refute the hypothesis 
of a single, universal cytokine storm underlying all fatal inﬂ  u-
enza diseases. Research is thus crucially needed to identify 
sets of virulence markers and to examine whether treatment 
should be tailored to the inﬂ  uenza virus pathotype.
A
ccording to the World Health Organization, inﬂ  uenza 
annually infects 5%–15% of the global population, 
causing 3–5 million cases of severe illness and ≈500,000 
reported deaths. The persistence of inﬂ   uenza A virus 
(H5N1) in poultry populations over the past 6 years and 
the ability of those viruses to cause fatal infections in hu-
mans, along with the recent pandemic (H1N1) 2009 out-
breaks, have raised fears of a renewed catastrophic inﬂ  u-
enza outbreak comparable to that of 1918, which caused 
death in 0.2%–8% of those infected in various countries 
and ≈50 million deaths worldwide (1). Standard inﬂ  uenza 
symptoms include fever, cough, headache, sore throat, and 
dehydration, with some reports of diarrhea, vomiting, and 
bleeding from the mouth or throat. In benign cases, not 
all of these symptoms are exhibited. In severe cases, ad-
ditional signs typical of either secondary bacterial pneumo-
nia or acute respiratory distress syndrome (ARDS) occur. 
Notably, these 2 manifestations are those that cause death 
in patients with inﬂ  uenza, whether seasonal or pandemic 
or caused by the 1918 subtype H1N1 strain or by recent 
subtype H5N1 strains. 
The catastrophic lethality of the 1918 pandemic makes 
it paramount that we understand the disease pathogenesis 
of both severe forms of inﬂ  uenza. Because most secondary 
bacterial pneumonias can be controlled with antimicrobial 
agents, prevention and treatment of inﬂ  uenza-associated 
ARDS are the major medical challenges that must be ad-
dressed to reduce the inﬂ  uenza-related death rate. This re-
quires more knowledge about the pathogenesis of ARDS. 
Alterations in human and mouse lungs have been described 
for fatal virus infections with pandemic virus strains (sub-
types H1N1, H2N2, and H3N2 strains of 1918, 1957, and 
1968, respectively) or subtype H5N1 strains. They are all 
characterized by similar lung dysfunctions and lesions 
(2,3). The lung becomes ﬂ  ooded as its alveolocapillary 
membranes leak, and the alveoli ﬁ  ll with body ﬂ  uids. Con-
sequently, the exchange of carbon dioxide and oxygen is 
reduced, and fatal acute lung failure ensues. The histologic 
ﬁ  ndings depend on the stage of the disease. Edema, epi-
thelial necrosis, ﬁ  brin, and hyaline membranes are found 
during the early exudative phase, and ﬁ  broblast and type 
II cell hyperplasia are found during the proliferative phase. 
This array of morphologic alterations is known as diffuse 
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alveolar damage. Moreover, mice infected with the 1918 
inﬂ  uenza virus or with a recent subtype H5N1 human iso-
late also show considerable similarities in overall lung cel-
lularity, composition of lung immune cell subpopulation, 
and cellular immune temporal dynamics (4). On the basis 
of these mostly retrospective studies, the pathogenesis of 
inﬂ  uenza-associated ARDS is widely viewed as being the 
same whatever the infecting strain.
In this study, we closely monitored ARDS in mice, 
caused by inoculation of identical doses of 2 different in-
ﬂ  uenza strains rendered highly pathogenic toward mice by 
adaptation. The 2 strains elicited dramatically different dis-
ease courses and histopathologic signatures, although both 
strains caused death in 100% of those infected, evoked the 
expected diffuse alveolar damage, and led to comparable 
virus titers in the lungs. The pathogenesis underlying inﬂ  u-
enza-associated fatal ARDS thus depended on the infecting 
strain.
Materials and Methods
Animals
Eight-week-old female FVB/J mice weighing 20–25 g 
were obtained from Charles River Laboratories (L’Arbresle, 
France). Challenge studies were conducted under BioSafe-
ty Level 3 laboratory conditions and in facilities accredited 
by the Belgian Council for Laboratory Animal Science, 
under the guidance of the Institutional Animal Care and 
Use Committees of the Veterinary Agrochemical Research 
Center and University of Liège. The mice were housed in 
microisolator cages ventilated under negative pressure with 
HEPA-ﬁ  ltered air. The light/dark cycle was 12/12 h, and 
the animals were allowed free access to food and water. Be-
fore each inoculation or euthanasia procedure, the animals 
were anesthetized by intraperitoneal injection of a mixture 
of ketamine (50 mg/kg) and xylazine (30 mg/kg).
Viruses
Two inﬂ  uenza A virus strain subtypes that had low 
pathogenicity for laboratory mice were used in this study: 
a clade 1 avian inﬂ  uenza virus (H5N1) (A/crested_eagle/
Belgium/1/2004), and a porcine inﬂ  uenza virus (H1N1) 
(A/swine/Iowa/4/76). Both viruses were ﬁ  rst propagated in 
the allantoic cavity of 10-day-old embryonating hen eggs 
and then adapted to the mice by lung-to-lung passaging. 
At each passage, a set of mice were inoculated intranasally 
with 50 μL of either allantoic ﬂ  uid or lung homogenate 
containing inﬂ  uenza A virus. At 5 days postinoculation 
(dpi), the mice were killed humanely by an overdose of 
pentobarbital, followed by exsanguination. The lungs were 
combined and homogenized in phosphate-buffered saline 
(PBS)–penicillin-streptomycin, the homogenates were 
centrifuged at 3,000 g for 10 min, and the supernatant was 
used for the next passage. The process was stopped when 
the mice showed a substantial loss of bodyweight on 4 dpi. 
This occurred after 5 (H5N1) or 31 (H1N1) passages. Lung 
homogenates from the last passage were homogenized and 
divided into aliquots for direct use in pathotyping studies, 
and their titers were determined by standard plaque (sub-
type H1N1) or median tissue culture infective dose assays 
(H5N1). Serial dilutions of each adapted virus stock were 
then injected into FVB/J mice, and the 50% mouse lethal 
dose (MLD50) was calculated according to the method of 
Reed and Muench (5).
Pathotyping Studies
For assessment of virus-induced pathogenicity, 2 se-
ries of mice were inoculated intranasally with 10 MLD50 of 
virus by instillation of 50 μL of diluted stock. Mice were 
monitored daily for changes in bodyweight to assess virus-
induced illness. At selected intervals, 5 (virus titration or 
histopathology) or 10 (virus titration + dry/wet weight ra-
tio) mice were given an overdose of sodium pentobarbital 
and exsanguinated by cutting the brachial artery. Lungs 
and pieces of heart, liver, spleen, pancreas, kidney, brain, 
and adipose tissue from 5 mice were ﬁ  xed in 4% neutral-
buffered, ice-cold paraformaldehyde, routinely processed, 
and embedded in parafﬁ  n for histopathologic evaluation. 
Five-micrometer sections were stained with hematoxylin 
and eosin (HE) or periodic acid–Schiff (PAS) for lesion 
detection. For virus detection, sections were stained by a 
streptavidin-biotin complex immunoperoxidase method. 
An in-house immunoglobulin (Ig) G–puriﬁ  ed polyclonal 
rabbit antiserum raised against recombinant inﬂ  uenza vi-
rus nucleoprotein was used as the source of primary an-
tibodies, and horseradish peroxidase (HRP)–conjugated 
anti–rabbit IgGs (Dako, Glostrup, Denmark) were used 
as secondary antibodies. Peroxidase was indicated by the 
bright red precipitate produced in the presence of 3-amino-
9-ethyl-carbazole, and sections were counterstained with 
Mayer hematoxylin. For virus titrations, lungs from 5 mice 
were weighed, homogenized in 1 mL PBS, and clariﬁ  ed. 
The supernatants were used for virus titration by plaque 
or median tissue culture infectious dose assays. Because 
the appearance of a biphasic expiratory pattern has been 
shown to announce death within ≈24 h (6), this qualitative 
sign was chosen, for humane reasons, as the endpoint of the 
experimental disease. On this endpoint day, lungs from 5 
mice were sampled and weighed, and homogenates thereof 
were desiccated for dry weight determination.
Results
Clinical, Gross Pathologic, and Virologic Observations
The inﬂ   uenza A virus strains (subtypes H1N1 and 
H5N1) used in this study were isolated, respectively, from 
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a diseased pig in the United States in 1976 and from a crest-
ed eagle smuggled from Thailand in 2003 (7). Both were 
nonpathogenic for FVB/J mice (MLD50 >106 PFU/50% 
tissue culture infective dose [TCID50]). After adaptation, 
the strains showed a similar pathogenic outcome in FVB/J 
mice, i.e., close MLD50 values: 3.2 PFUs for the subtype 
H1N1 strain and 6.4 TCID50 for the subtype H5N1 strain. 
These results allowed a relevant comparison of their respec-
tive pathologic signatures. Overall, virus-associated illness, 
bodyweight loss, and gross lesions caused by inoculation of 
10 MLD50 were similar for both viruses, except that body 
condition and respiratory function deteriorated far more 
rapidly after subtype H5N1 inoculation, the endpoint being 
reached on 4 dpi for subtype H5N1–induced disease and 
8 dpi for subtype H1N1–induced disease. The pathologic 
processes caused no symptoms for the ﬁ  rst 2 (H5N1) or 
3 (H1N1) days and then gave rise to general signs such as 
gradually slower, less frequent, and more erratic sponta-
neous displacements and a rufﬂ  ed coat. By 3 dpi (H5N1) 
or 5 dpi (H1N1), all mice became lethargic and abruptly 
showed clinical signs of respiratory disease, including re-
spiratory distress, labored breathing, and forced expiration. 
Mice inoculated with subtype H5N1 lost 10% of their body-
weight during the last 48 hours before the endpoint day. In 
mice that were inoculated with subtype H1N1, weight loss 
was acute and biphasic: a 10% loss occurred between virus 
inoculation and the appearance of respiratory symptoms, 
and an additional 20% was lost during ARDS (Figure 1). 
Autopsies performed on the endpoint day of subtype H1N1 
disease consistently showed dark, purplish, bulky, noncrep-
itant, liverlike lungs, ﬁ  ndings compatible with a diagnosis 
of massive pulmonary congestion and consolidation. In 
subtype H5N1–inoculated mice, the lungs at endpoint were 
bulky, noncrepitant, and diffusely pinkish gray, which sug-
gests a diagnosis of congestion with massive pulmonary 
edema. Mice inoculated with either virus had a lung wet 
weight at endpoint approximately double that of controls, 
but this weight gain was achieved during the last ≈24 hours 
in mice inoculated with subtype H5N1, whereas mice in-
oculated with subtype H1N1 showed a progressive lung 
weight increase over 96 hours, from 4 dpi to the endpoint 
day (Figure 2). At the endpoint, the dry/wet weight ratio 
of the lungs was ≈22% lower for subtype H5N1-infected 
mice (17.6% ± 1.1%) than for subtype H1N1-infected mice 
(21.4% ± 1.4%). No obvious gross lesions were observed 
in the heart, liver, spleen, kidney, brain, or perivisceral fat. 
The lung virus loads measured on 2, 4, 6, and 8 dpi are 
shown in Figure 3. The time required to reach the peak vi-
rus titer was the same for both virus strains. Death occurred 
at the peak lung virus concentration for subtype H5N1, but 
subtype H1N1–associated disease did not become fatal un-
til 4 days after this peak, when virus clearance was already 
substantial (Figure 3).
Histopathologic Observations
An exhaustive list of the histopathologic lesions 
caused by the 2 viruses is given in the online Appendix 
Table (www.cdc.gov/EID/content/16/4/595-appT.htm). 
Some changes in lung morphology were identical for both 
viruses. First, a clear topographic extension of the lesions 
was perceptible between the ﬁ  rst and the last day of infec-
tion, with centrifugal spreading from the terminal bronchi-
oles or the alveoli adjacent to the airways. Qualitatively, 
all alterations characterizing the exudative phase of the 
histopathologic condition termed diffuse alveolar damage 
were identiﬁ  able, with intense congestion of the alveolar 
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Figure 1. Effect of inﬂ  uenza A virus subtype H5N1 (A) and H1N1 (B) strains on bodyweight gain or loss after intranasal inoculation of 10× 
the 50% mouse lethal dose on day 0. Relative values are given, as calculated with respect to preinoculation control values (mean ± SD). 
For each virus strain, means signiﬁ  cantly different from baseline are indicated (Student t test for paired values). *p<0.05; †p<0.01. RESEARCH
capillaries, marginated intracapillary neutrophils, necrosis 
of the alveolar epithelium, interstitial and alveolar edema, 
hyaline membranes, and invasion of the alveoli by (most-
ly) mononucleate cells. On the other hand, we did not ob-
serve cuboidalization of the alveoli (hyperplasia of type 
II pneumocytes) or hyperplasia or squamous metaplasia 
of the airway epithelia. These results indicate extremely 
rapid disease progression, nearly complete elimination of 
type II pneumocytes, or both. Despite these similarities, 
when sections of lung tissue samples taken on the last day 
from infected mice were pooled by subtype, an examiner 
unaware of which infection he was looking could easily 
distinguish one from the other (Figures 4, 5). The crite-
ria for attributing lung lesions to the subtype H1N1 strain 
were the following: 1) earlier and much more extensive 
degeneration, necrosis, and desquamation of the airway 
epithelium; 2) a much higher cell density of the peribron-
chial, peribronchiolar, interstitial, and intra-alveolar inﬁ  l-
trates; 3) the presence of dense cuffs of mononucleate cells 
around the arterioles; 4) far less extensive alveolar ede-
mas; and 5) the rarity of alveolar hemorrhages. The lesions 
caused by the subtype H5N1 strain were distinguishable 
by the late and mild regressive alterations of the airway ep-
ithelium, the extent of alveolar edema, the low cell density 
of the inﬂ  ammatory inﬁ  ltrates, the high number of alveolar 
hemorrhage foci, and the unusual appearance of the pul-
monary arterioles (which seemed to have been dissected 
from the surrounding tissues because of the magnitude of 
the perivascular edema). 
On the other hand, no arteriole showed any cuff of in-
ﬁ  ltrated mononucleate cells. Some blood-vessel walls also 
showed hemorrhage inside the muscle layer. No other or-
gan examined was found to carry any histopathologic le-
sions except, notably, the liver in subtype H5N1–infected 
mice (Figure 5). These livers displayed multifocal necrosis, 
with necrotic foci consisting of aggregates of hypereosino-
philic, pyknotic, and caryorhectic hepatocytes, admixed 
with a few neutrophils and lymphocytes. Such foci were 
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Figure 2. Effect of inﬂ  uenza A virus 
subtype H5N1 and H1N1 strains 
on lung weight after intranasal 
inoculation of 10× the 50% mouse 
lethal dose on day 0. Absolute 
values are given as means ± SD for 
5 mice at each time point. For each 
virus strain, means signiﬁ  cantly 
different from those of control (CTL) 
lungs are indicated (nonparametric 
Mann-Whitney test). *p<0.05; 
†p<0.01.
Figure 3. Effect of inﬂ  uenza  A 
virus subtype strains H5N1 and 
H1N1 on lung virus titers 2–8 
days after intranasal inoculation of 
10× the 50% mouse lethal dose 
on day 0. Titers are expressed 
as the log10 median tissue culture 
infectious dose (TCID50) units 
per milliliter of lung homogenate. 
Signiﬁ   cantly different titers are 
indicated (nonparametric Mann-
Whitney test). Error bars indicate 
SD calculated from individual virus 
titers. *p <0.05.Inﬂ  uenza Strain-Dependent Pathogenesis
also seen in the spleen in some animals. Strikingly, numer-
ous PAS-positive islets were detected throughout the liv-
ers of subtype H5N1–infected animals, each overlapping 
with a necrotic focus. Patterns of centrolobular, hydropic, 
granular (2 dpi), centrolobular (3 dpi), and panlobular (4 
dpi) microvesicular fatty degeneration were also observed 
in the livers of all subtype H5N1-infected animals. Intersti-
tial hemorrhages were seen in the renal medulla.
Detection of Viruses in Tissues
The results of immunohistochemical tests were homo-
geneous for mice infected with the same strain. Overall, 
they showed that the subtype H1N1 strain swarmed cen-
trifugally from the bronchioles throughout the lungs over 
4–5 days, but remained strictly conﬁ  ned to the lungs. The 
subtype H5N1 virus, in contrast, conquered the whole lung 
over 24–48 hours; infected some bronchioles only later; 
and spread to the liver, pancreas, kidneys, spleen, brain, 
and perivisceral fat.
Topologic Distribution of Subtype H1N1 
Antigens over Time
The virus was ﬁ  rst detectable in the epithelium of the 
bronchi and bronchioles on 3 dpi. By 5 dpi, the stain was 
more conspicuous and appeared also in the alveolar epi-
thelium of the areas adjacent to the airways. By 7 dpi, the 
virus was detectable in the epithelia of almost all bronchi 
and bronchioles and in the alveolar epithelium in exten-
sive areas of the lungs. In the alveolar structures, staining 
showed the virus in type I and type II pneumocytes and 
in alveolar macrophages (Figure 6, panels A, C, and E). 
Nonrespiratory organs sampled on 3, 5, or 7 dpi remained 
strictly virus negative.
Topologic Distribution of Subtype H5N1 
Antigens over Time
The virus was detectable from 2 dpi in some type II 
pneumocytes in peribronchiolar alveoli, some interstitial/
alveolar macrophages, and some endothelial cells in the 
vicinity of the positive alveoli. In contrast, no nonrespira-
tory organ examined showed any virus-positive cells. By 
3 dpi, staining of the airway epithelium was still discrete 
and limited, whereas the alveolar epithelium showed more 
pronounced staining, diffusely distributed throughout the 
lung. In the liver, multiple nests of positive hepatocytes 
were detectable, corresponding exactly with the above-
mentioned necrotic PAS-positive foci. A few renal tubular 
epithelial cells were also positive. On 4 dpi, the alveolar 
epithelium was still diffusely stained, but more intensely 
than on 3 dpi. For the ﬁ  rst time, staining of the bronchiolar 
epithelium was also visible, but not all bronchioles—far 
from all, in fact—showed this staining. Type II pneumo-
cytes and alveolar macrophages were more often positive 
than type I pneumocytes (Figure 6, panels B, D, and F). 
The appearance of the kidneys and liver was the same as on 
3 dpi, with more conspicuous staining. Additionally, virus-
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Figure 4. Photomicrographs of the lung sections of inﬂ  uenza A virus (H1N1)– and (H5N1)–infected mice at endpoint (hematoxylin and 
eosin stain). Dramatically different histopathologic signatures are observed, with either a mostly cellular reaction (H1N1) or a mostly 
humoral reaction (H5N1). Panels A, D, and G: 3 views of vehicle-infected lungs (original magniﬁ  cation ×100). Panels B and E, subtype 
H1N1: Dense granulocytic and lymphocytic cell inﬁ  ltrates in the interstitium and around vessels and airways with focally denuded lamina 
propria due to epithelial necrosis and desquamation (original magniﬁ  cation ×100). Panel C, subtype H5N1: Airway epithelium is intact; 
note the striking difference in the number of inﬁ  ltrated inﬂ  ammatory cells between subtypes H1N1- and H5N1-infected lungs. Dramatic 
congestion of the vessels is visible, with extensive interstitial and alveolar edema (original magniﬁ  cation ×100). Panel F, subtype H5N1: 
Alveoli are completely ﬁ  lled with edema and hemorrhages; cellular inﬁ  ltrates are conspicuously absent (original magniﬁ  cation ×200). 
Panel H, subtype H1N1: An airway with a totally denuded lamina propria is shown (top, left), with its lumen ﬁ  lled with granulocytic and 
lymphocytic exsudate (original magniﬁ  cation ×200). A prominent periarteriolar lymphocytic cuff is visible (bottom right). Panel I, subtype 
H5N1: Moderate inﬂ  ammatory cell inﬁ  ltrate, with no cufﬁ  ng of any airway or vessel; an airway with a still intact epithelium is shown, located 
just beside a vessel with dramatic peripheral edema (original magniﬁ  cation ×200). RESEARCH
positive glial cells, splenic macrophages, cardiomyocytes, 
islets of Langerhans cells, and peritoneal adipocytes were 
also detected (Figure 7).
Discussion
Two inﬂ  uenza A viruses of different subtypes, de-
rived from different species and showing no pathogenicity 
toward mice, were forced to evolve by serial passaging in 
mouse lungs. The 2 adapted viruses obtained showed prac-
tically identical virulence levels, with similar MLD50 val-
ues. On the basis of this criterion, they appear to be more 
virulent than most other viruses used to date in murine 
models (4,8–16). Their virulence is of the same order of 
magnitude as those of the A/Vietnam/1203/2004 (H5N1) 
and A/Vietnam/1204/2004 (H5N1) viruses, whose respec-
tive MLD50s are 0.7 and 2.1 PFUs (17). In both cases, in-
oculation of 10 MLD50 causes biphasic weight loss, cul-
minating in death with a loss of ≈10% (H5N1) or ≈25% 
(H1N1) bodyweight. Viral ampliﬁ  cation is maximal for 
both viruses on 4 dpi, roughly corresponding to the typical 
inoculation-to-peak lag of natural murine respiratory vi-
ruses (6,18). On the other hand, the 2 viruses adapted in the 
lungs showed replication kinetics that differed substantial-
ly from what is observed with natural viruses, with a quasi-
plateau from 2 to 5/6 dpi instead of the classical Gaussian 
proﬁ  le. Notably, this peculiar ampliﬁ  cation kinetics pro-
ﬁ  le has been described previously for mice infected with 
mouse-adapted forms of the A/Puerto Rico/8/34 (H1N1) 
virus (19), the A/South Carolina/1/18 (H1N1) virus (4), 
and several human subtype H5N1 strains showing high or 
low pathogenicity (4,14). These reports suggest that this 
proﬁ  le is typical of inﬂ  uenza virus ampliﬁ  cation by the 
murine respiratory system. 
A ﬁ  nal common feature of infection with the 2 virus 
subtypes was diffuse alveolar damage, which dominates 
both histopathologic proﬁ  les; these results corroborate the 
pathologic data found in the literature. Seasonal human in-
ﬂ  uenza epidemics typically consist of a transient tracheo-
bronchitis caused by preferential attachment of the virus to 
the laryngeal, tracheal, and bronchial epithelia. In contrast, 
those inﬂ  uenza viruses which are highly pathogenic toward 
humans, from the pandemic viruses of 1918 (H1N1), 1957 
(H2N2), and 1968 (H3N2) to the subtype H5N1 strains 
isolated from humans since 2003, additionally colonize 
the bronchiolar and alveolar epithelia, preferentially or not, 
and cause diffuse alveolar damage as an additional primary 
lesion (20–23). The same lesion has been found in experi-
mental animals injected with a recent subtype H5N1 strain 
(14,24–26).
Although both viruses share the same pathogenicity, 
replication kinetics, and concentration peak, and although 
they both evoke diffuse alveolar damage by the endpoint 
day, they differ dramatically in terms of the ARDS course 
and pathologic signature. Flagrant differences make it easy 
to distinguish infections by the 2 subtypes. In subtype 
H1N1 infection, the disease becomes fatal at a point when 
the pulmonary edema is much less intense and leaves a 
histopathologic picture characterized by much more dense 
inﬂ  ammatory cell inﬁ  ltrates, generating cuffs around the 
bronchioles and blood vessels. Second, subtype H1N1 col-
onizes the epithelia of both the upper and lower airways, 
without any obvious preference, whereas subtype H5N1 
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Figure 5. Photomicrographs of liver, spleen, 
and lung sections from inﬂ  uenza  virus  A 
(H5N1)–infected mice at endpoint. Necrotic 
foci (arrows) scattered throughout the liver 
(A) (original magniﬁ  cation ×200) and spleen 
(B) (original magniﬁ   cation ×100) from 
subtype H5N1–infected mice (hematoxylin 
and eosin stain); these foci are absent 
from subtype H1N1–infected mouse livers. 
C) Necrotic foci in the liver stain periodic 
acid–Schiff (PAS)–positive (arrow), which 
suggests focal accumulation of glycogen 
(original magniﬁ   cation ×400). D) Numerous 
alveolar walls lined with PAS-stained hyaline 
membranes (arrows), suggestive of necrosis 
and desquamation of pneumocytes (original 
magniﬁ  cation ×1,000).Inﬂ  uenza Strain-Dependent Pathogenesis
remains conﬁ  ned essentially to the alveoli and terminal 
bronchioles. Within the alveoli, unlike the subtype H1N1 
strain, the subtype H5N1 strain shows a preferential tro-
pism for type II pneumocytes and alveolar macrophages. 
Lastly, whereas subtype H1N1 remains strictly conﬁ  ned 
to the respiratory system, subtype H5N1 spreads to other 
organs. These differences demonstrate unambiguously that 
the 2 highly virulent inﬂ  uenza A viruses studied here cause 
2 different forms of ARDS. This ﬁ  nding suggests that the 
physiopathologic data obtained when studying 1 virulent 
strain should not be extrapolated automatically to other 
strains. The observed differences also suggest that diverse 
constellations of critical mutations in the viral genome 
might lead to the same fatal result. 
This work addresses the question of possible differ-
ences between 2 fatal diseases caused by inﬂ  uenza A vi-
ruses, although some previous evidence that pointed in the 
same direction has already been reported. For example, 
the pandemic human strains of 1918, 1957, and 1968, on 
the one hand, and the recent subtype H5N1 strains, on the 
other, show different tropisms: panepithelial for the former 
strains (20,27,28) and limited to the bronchiolar and alveo-
lar epithelia for the latter strains, a result compatible with 
our own observations on mouse-adapted viruses. Likewise, 
a panepithelial tropism has been observed for the A/South 
Carolina/1/18 (H1N1) virus in mice (29), whereas a prefer-
ence for the bronchioles and alveoli has been noted for re-
cent subtype H5N1 strains that have been injected into ma-
caques, mice, ferrets, and cats (14,25,30–37). In addition, 
the observed strict conﬁ  nement of our subtype H1N1 strain 
to the respiratory system conﬁ  rms previously reported data 
that refute the existence of polysystemic dissemination of 
non-H5 viruses that are lethal to humans or laboratory ani-
mals (20,27,29,38). Conversely, our observation that the 
subtype H5N1 strain spreads beyond the respiratory system 
conﬁ  rms similar observations of both humans (22,22,39) 
and laboratory animals (14,24,25,30–34).
Although other subtype H5N1 and subtype H1N1 
viruses infect other susceptible hosts, they may not show 
trends similar to those observed here. These results, when 
integrated with the diverse pieces of evidence reported 
elsewhere, suggest that fatal infections caused by different 
highly virulent inﬂ  uenza A viruses do not necessarily share 
the same pathogenesis. To be convinced, one has only to 
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Figure 6. Topologic distribution of inﬂ  uenza antigens in the lungs of mice infected with inﬂ  uenza virus A subtype H1N1 and H5N1 strains 
at endpoint (antinucleoprotein immunohistochemical staining). A) Subtype H1N1 and B) subtype H5N1, both showing diffusely distributed 
positive staining of numerous pneumocytes and alveolar macrophages (original magniﬁ  cation ×100). C) Subtype H1N1, showing antigens 
massively present in the remaining non-desquamated airway epithelial cells (original magniﬁ  cation ×400); viral ampliﬁ  cation in type I and 
type II pneumocytes is far more intense and widespread 4 days after inoculation of the subtype H5N1 virus (D) than 7 days after inoculation 
of the subtype H1N1 virus (original magniﬁ  cation ×400). E) Desquamated, necrotic, and intensely virus-positive airway epithelial cells in 
a terminal bronchiole and adjacent alveoli of a mouse infected with subtype H1N1, compared with F) uninfected, intact airway epithelial 
cells in a terminal bronchiole and adjacent alveoli of a mouse infected with subtype H5N1, illustrating the different pneumotropism of the 
2 viruses (original magniﬁ  cation ×1,000). Conversely, the density of virus-positive cells in the lung/alveoli is higher after inoculation of the 
subtype H5N1 strain (Mayer hematoxylin counterstain).RESEARCH
note the ease of distinguishing, in the absence of any virus 
labeling, the histopathologic sections typical of the 2 strains 
used here (Figure 4). These different histopathologic signa-
tures and different pathogeneses probably reﬂ  ect the pres-
ence of speciﬁ  c sets of virulence markers that will have to 
be decrypted to anticipate the emergence of a pandemic. In 
this respect, sequence analysis of both strains will lead to 
insight on speciﬁ  c residues that are relevant for the adapta-
tion and virulence of an inﬂ  uenza strain in a new host. 
Furthermore, the differences between these 2 strains 
suggest that >1 universal cytokine storm underlies fatal in-
ﬂ  uenza diseases. Thus, it might be advantageous to tailor 
the therapeutic approach to the inﬂ  uenza virus pathotype.
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